Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison.
Brisse HJ, Guesmi M, Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Desjardins L, Doz F, Asselain B, Bours D, Neuenschwander S. Brisse HJ, et al. Among authors: savignoni a. Pediatr Radiol. 2007 Jul;37(7):649-56. doi: 10.1007/s00247-007-0491-4. Epub 2007 May 4. Pediatr Radiol. 2007. PMID: 17479257
[HRT in post menopausal women and breast cancer at the Institut Curie].
Czernichow C, This P, Asselain B, Falcou MC, Savignoni A, Salmon RJ; Groupe sein de l'Institut Curie; Sigal-Zafrani B. Czernichow C, et al. Among authors: savignoni a. Bull Cancer. 2007 May;94(5):469-75. Bull Cancer. 2007. PMID: 17535785 Free article. French.
Pilot evaluation of a French interdisciplinary supportive care department.
Brédart A, Dolbeault S, Savignoni A, Simard S, Gomme S, Asselain B, Copel L. Brédart A, et al. Among authors: savignoni a. Support Care Cancer. 2009 Dec;17(12):1507-16. doi: 10.1007/s00520-009-0617-3. Epub 2009 Apr 3. Support Care Cancer. 2009. PMID: 19343371
Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients.
De Cremoux P, Grandin L, Diéras V, Savignoni A, Degeorges A, Salmon R, Bollet MA, Reyal F, Sigal-Zafrani B, Vincent-Salomon A, Sastre-Garau X, Magdelénat H, Mignot L, Fourquet A; Breast Cancer Study Group of the Institut Curie. De Cremoux P, et al. Among authors: savignoni a. Anticancer Res. 2009 May;29(5):1475-82. Anticancer Res. 2009. PMID: 19443353 Free article.
Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment.
Bollet MA, Savignoni A, De Koning L, Tran-Perennou C, Barbaroux C, Degeorges A, Sigal-Zafrani B, Almouzni G, Cottu P, Salmon R, Servant N, Fourquet A, de Cremoux P. Bollet MA, et al. Among authors: savignoni a. Breast Cancer Res. 2009;11(4):R54. doi: 10.1186/bcr2343. Epub 2009 Jul 28. Breast Cancer Res. 2009. PMID: 19638208 Free PMC article.
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.
Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A. Kirova YM, et al. Among authors: savignoni a. Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033769 Review.
95 results